Gilead Sciences Spikes Amid CVS Formulary Status By: Benzinga via Benzinga January 05, 2015 at 12:32 PM EST Shares of Gilead Sciences, Inc. (NASDAQ: GILD) spiked up over 3 percent Monday amid news that CVS Health Corp (NYSE: CVS) gave ... Read More >> Related Stocks: CVS Health Corp Gilead Sciences